Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1997;5(2):115–120. doi: 10.1155/S1064744997000185

Materno-Fetal Transmission of Human Immune Deficiency Virus

Axel Schäfer 1,2,✉
PMCID: PMC2364568  PMID: 18476163

Abstract

Mother-to-child transmission of human immune deficiency virus (HIV) is a multifactorial event highly associated with advanced maternal HIV disease and obstetric incidents taking place during parturition. Thus, various approaches to prevention may be beneficial. Although the time and the route of materno-fetal HIV transmission are still not sufficiently clear, much speaks in favor of a late HIV transmission, most probably taking place during parturition or the phase before the delivery. The fetus is remarkably protected by the placenta and the intact fetal membranes against many viral infections during gestation. These conditions change at parturition and the chance for a transition of HIV-infected carrier cells or virus into the fetal compartment increases. Proinflammatory cytokines secreted at the materno-fetal interface accumulate in amniotic fluid and may chemoattract and stimulate potentially HIV-infected immunocytes. After rupture of membranes, maternal cells of the decidua are directly exposed to the amniotic fluid. Aside from the contamination of the fetal skin at vaginal delivery as a debatable route of infection, blood-to-blood contacts and the fetal swallowing of contaminated amniotic fluid may be the major path of fetal HIV infection. For the fetal prophylaxis of an intrauterine infection, the application of zidovudine is recommended. However, cesarian section before the onset of labor leads also to a diminution of the transmission rate. As the transmission seems to have both systemic and local causes, it makes sense to combine different intervention strategies. Whether a combination of zidovudine and elective cesarean section can lower the transmission risk further has to be evaluated.

Full Text

The Full Text of this article is available as a PDF (512.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baba T. W., Koch J., Mittler E. S., Greene M., Wyand M., Penninck D., Ruprecht R. M. Mucosal infection of neonatal rhesus monkeys with cell-free SIV. AIDS Res Hum Retroviruses. 1994 Apr;10(4):351–357. doi: 10.1089/aid.1994.10.351. [DOI] [PubMed] [Google Scholar]
  2. Backé E., Jiménez E., Unger M., Schäfer A., Jauniaux E., Vogel M. Demonstration of HIV-1 infected cells in human placenta by in situ hybridisation and immunostaining. J Clin Pathol. 1992 Oct;45(10):871–874. doi: 10.1136/jcp.45.10.871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Backé E., Unger M., Jimenez E., Siegel G., Schäfer A., Vogel M. Fetal organs infected by HIV-1. AIDS. 1993 Jun;7(6):896–897. doi: 10.1097/00002030-199306000-00025. [DOI] [PubMed] [Google Scholar]
  4. Bazzoni F., Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med. 1996 Jun 27;334(26):1717–1725. doi: 10.1056/NEJM199606273342607. [DOI] [PubMed] [Google Scholar]
  5. Bertolli J., St Louis M. E., Simonds R. J., Nieburg P., Kamenga M., Brown C., Tarande M., Quinn T., Ou C. Y. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire. J Infect Dis. 1996 Oct;174(4):722–726. doi: 10.1093/infdis/174.4.722. [DOI] [PubMed] [Google Scholar]
  6. Biggar R. J., Miotti P. G., Taha T. E., Mtimavalye L., Broadhead R., Justesen A., Yellin F., Liomba G., Miley W., Waters D. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet. 1996 Jun 15;347(9016):1647–1650. doi: 10.1016/s0140-6736(96)91486-5. [DOI] [PubMed] [Google Scholar]
  7. Borkowsky W., Krasinski K., Cao Y., Ho D., Pollack H., Moore T., Chen S. H., Allen M., Tao P. T. Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes. J Pediatr. 1994 Sep;125(3):345–351. doi: 10.1016/s0022-3476(05)83274-3. [DOI] [PubMed] [Google Scholar]
  8. Boyer P. J., Dillon M., Navaie M., Deveikis A., Keller M., O'Rourke S., Bryson Y. J. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA. 1994 Jun 22;271(24):1925–1930. [PubMed] [Google Scholar]
  9. Caesarean section and risk of vertical transmission of HIV-1 infection. The European Collaborative Study. Lancet. 1994 Jun 11;343(8911):1464–1467. [PubMed] [Google Scholar]
  10. Casey M. L., Cox S. M., Beutler B., Milewich L., MacDonald P. C. Cachectin/tumor necrosis factor-alpha formation in human decidua. Potential role of cytokines in infection-induced preterm labor. J Clin Invest. 1989 Feb;83(2):430–436. doi: 10.1172/JCI113901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Connor E. M., Sperling R. S., Gelber R., Kiselev P., Scott G., O'Sullivan M. J., VanDyke R., Bey M., Shearer W., Jacobson R. L. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994 Nov 3;331(18):1173–1180. doi: 10.1056/NEJM199411033311801. [DOI] [PubMed] [Google Scholar]
  12. David F. J., Tran H. C., Serpente N., Autran B., Vaquero C., Djian V., Menu E., Barré-Sinoussi F., Chaouat G. HIV infection of choriocarcinoma cell lines derived from human placenta: the role of membrane CD4 and Fc-Rs into HIV entry. Virology. 1995 Apr 20;208(2):784–788. doi: 10.1006/viro.1995.1212. [DOI] [PubMed] [Google Scholar]
  13. Ehrnst A., Lindgren S., Dictor M., Johansson B., Sönnerborg A., Czajkowski J., Sundin G., Bohlin A. B. HIV in pregnant women and their offspring: evidence for late transmission. Lancet. 1991 Jul 27;338(8761):203–207. doi: 10.1016/0140-6736(91)90347-r. [DOI] [PubMed] [Google Scholar]
  14. Erb P., Kräuchi S., Bürgin D., Biedermann K., Camli C., Rudin C. Quantitative anti-p24 determinations can predict the risk of vertical transmission. Swiss HIV and Pregnancy Collaborative Study Group. J Acquir Immune Defic Syndr. 1994 Mar;7(3):261–264. [PubMed] [Google Scholar]
  15. European Collaborative Study Risk factors for mother-to-child transmission of HIV-1. Lancet. 1992 Apr 25;339(8800):1007–1012. doi: 10.1016/0140-6736(92)90534-a. [DOI] [PubMed] [Google Scholar]
  16. Fan S. T., Hsia K., Edgington T. S. Upregulation of human immunodeficiency virus-1 in chronically infected monocytic cell line by both contact with endothelial cells and cytokines. Blood. 1994 Sep 1;84(5):1567–1572. [PubMed] [Google Scholar]
  17. Fang G., Burger H., Grimson R., Tropper P., Nachman S., Mayers D., Weislow O., Moore R., Reyelt C., Hutcheon N. Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12100–12104. doi: 10.1073/pnas.92.26.12100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Goedert J. J., Duliège A. M., Amos C. I., Felton S., Biggar R. J. High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet. 1991 Dec 14;338(8781):1471–1475. doi: 10.1016/0140-6736(91)92297-f. [DOI] [PubMed] [Google Scholar]
  19. Goedert J. J., Mendez H., Drummond J. E., Robert-Guroff M., Minkoff H. L., Holman S., Stevens R., Rubinstein A., Blattner W. A., Willoughby A. Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120. Lancet. 1989 Dec 9;2(8676):1351–1354. doi: 10.1016/s0140-6736(89)91965-x. [DOI] [PubMed] [Google Scholar]
  20. Hillier S. L., Witkin S. S., Krohn M. A., Watts D. H., Kiviat N. B., Eschenbach D. A. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol. 1993 Jun;81(6):941–948. [PubMed] [Google Scholar]
  21. Ho W. Z., Cherukuri R., Douglas S. D. The macrophage and HIV-1. Immunol Ser. 1994;60:569–587. [PubMed] [Google Scholar]
  22. Kliks S. C., Wara D. W., Landers D. V., Levy J. A. Features of HIV-1 that could influence maternal-child transmission. JAMA. 1994 Aug 10;272(6):467–474. [PubMed] [Google Scholar]
  23. Mandelbrot L., Mayaux M. J., Bongain A., Berrebi A., Moudoub-Jeanpetit Y., Bénifla J. L., Ciraru-Vigneron N., Le Chenadec J., Blanche S., Delfraissy J. F. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol. 1996 Sep;175(3 Pt 1):661–667. doi: 10.1053/ob.1996.v175.a75478. [DOI] [PubMed] [Google Scholar]
  24. Ometto L., Zanotto C., Maccabruni A., Caselli D., Truscia D., Giaquinto C., Ruga E., Chieco-Bianchi L., De Rossi A. Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. AIDS. 1995 May;9(5):427–434. [PubMed] [Google Scholar]
  25. Parekh B. S., Shaffer N., Pau C. P., Abrams E., Thomas P., Pollack H., Bamji M., Kaul A., Schochetman G., Rogers M. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study. AIDS. 1991 Oct;5(10):1179–1184. doi: 10.1097/00002030-199110000-00004. [DOI] [PubMed] [Google Scholar]
  26. Rouzioux C., Costagliola D., Burgard M., Blanche S., Mayaux M. J., Griscelli C., Valleron A. J. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group. Am J Epidemiol. 1995 Dec 15;142(12):1330–1337. doi: 10.1093/oxfordjournals.aje.a117601. [DOI] [PubMed] [Google Scholar]
  27. Rubinstein A., Sicklick M., Gupta A., Bernstein L., Klein N., Rubinstein E., Spigland I., Fruchter L., Litman N., Lee H. Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA. 1983 May 6;249(17):2350–2356. [PubMed] [Google Scholar]
  28. Ryder R. W., Nsa W., Hassig S. E., Behets F., Rayfield M., Ekungola B., Nelson A. M., Mulenda U., Francis H., Mwandagalirwa K. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med. 1989 Jun 22;320(25):1637–1642. doi: 10.1056/NEJM198906223202501. [DOI] [PubMed] [Google Scholar]
  29. Scarlatti G., Albert J., Rossi P., Hodara V., Biraghi P., Muggiasca L., Fenyö E. M. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J Infect Dis. 1993 Jul;168(1):207–210. doi: 10.1093/infdis/168.1.207. [DOI] [PubMed] [Google Scholar]
  30. Sperling R. S., Shapiro D. E., Coombs R. W., Todd J. A., Herman S. A., McSherry G. D., O'Sullivan M. J., Van Dyke R. B., Jimenez E., Rouzioux C. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1996 Nov 28;335(22):1621–1629. doi: 10.1056/NEJM199611283352201. [DOI] [PubMed] [Google Scholar]
  31. St Louis M. E., Kamenga M., Brown C., Nelson A. M., Manzila T., Batter V., Behets F., Kabagabo U., Ryder R. W., Oxtoby M. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA. 1993 Jun 9;269(22):2853–2859. [PubMed] [Google Scholar]
  32. Tovo P. A. Caesarean section and perinatal HIV transmission: what next? Lancet. 1993 Sep 11;342(8872):630–630. doi: 10.1016/0140-6736(93)91753-9. [DOI] [PubMed] [Google Scholar]
  33. Tovo P. A., de Martino M., Gabiano C., Galli L., Cappello N., Ruga E., Tulisso S., Vierucci A., Loy A., Zuccotti G. V. Mode of delivery and gestational age influence perinatal HIV-1 transmission. Italian Register for HIV Infection in Children. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jan 1;11(1):88–94. doi: 10.1097/00042560-199601010-00012. [DOI] [PubMed] [Google Scholar]
  34. Van de Perre P., Simonon A., Msellati P., Hitimana D. G., Vaira D., Bazubagira A., Van Goethem C., Stevens A. M., Karita E., Sondag-Thull D. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. N Engl J Med. 1991 Aug 29;325(9):593–598. doi: 10.1056/NEJM199108293250901. [DOI] [PubMed] [Google Scholar]
  35. Wei X., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995 Jan 12;373(6510):117–122. doi: 10.1038/373117a0. [DOI] [PubMed] [Google Scholar]
  36. Weiser B., Nachman S., Tropper P., Viscosi K. H., Grimson R., Baxter G., Fang G., Reyelt C., Hutcheon N., Burger H. Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8037–8041. doi: 10.1073/pnas.91.17.8037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Winchester R., Chen Y., Rose S., Selby J., Borkowsky W. Major histocompatibility complex class II DR alleles DRB1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: determination by an automated sequence-based typing method. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12374–12378. doi: 10.1073/pnas.92.26.12374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wolinsky S. M., Wike C. M., Korber B. T., Hutto C., Parks W. P., Rosenblum L. L., Kunstman K. J., Furtado M. R., Muñoz J. L. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science. 1992 Feb 28;255(5048):1134–1137. doi: 10.1126/science.1546316. [DOI] [PubMed] [Google Scholar]
  39. Zorr B., Schäfer A. P., Dilger I., Habermehl K. O., Kosh M. HIV-1 detection in endocervical swabs and mode of HIV-1 infection. Lancet. 1994 Apr 2;343(8901):852–852. [PubMed] [Google Scholar]
  40. Zöllner B., Feucht H. H., Helling-Giese G., Schröter M., Laufs R. HIV quantification: useful for prediction of vertical transmission? Lancet. 1996 Mar 30;347(9005):899–899. doi: 10.1016/s0140-6736(96)91376-8. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES